Jérémie Jourdan is a Local Partner at White & Case Brussels and Paris. He trained both in law (LLM, College of Europe) and economics and finance (Master's degree, University Paris IX-Dauphine).
Jérémie's practice focuses on advising clients in antitrust and merger control proceedings.
In recent years, he has been involved in several high profile antitrust investigations before the EU Commission and courts. For example, he is representing Les Laboratoires Servier before the Court of Justice in the largest case to date concerning patent settlement agreements in the pharmaceutical sector, which involved the application of both Articles 101 and 102. He has also been at the forefront of investigations in the financial sector, being one of the leading members of the White & Case team representing Crédit Agricole in the European Commission's Euribor investigation. He also secured a significant victory for Japanese company Toshiba Corporation in its challenges before EU Courts against the Commission cartel decision in Cathode Ray Tubes.
Jérémie has also represented clients before the European Commission in Phase I and Phase II merger control reviews, and advised clients in proceedings before the French competition authority. He routinely advises companies, in particular private equity funds, in multi-jurisdictional merger filings around the world.
Between 2010 and 2012, Jeremie worked at the European Commission as part of the Hearing Officers' team. In this role, he developed significant expertise on the procedural rules governing EU antitrust and merger proceedings, and was involved in several high profile antitrust and phase II merger proceedings.
Secured a significant victory for Japanese company Toshiba Corporation in its challenges before EU Courts against the Commission cartel decision in Cathode Ray Tubes (T-104/12). Also represented Toshiba in the Gas Insulated Switchgear (T-404/12) and Transformers (T-519/09) cartel appeals.
Representation of Crédit Agricole in the European Commission’s Euribor investigation.
Representation before the General Court of Les Laboratoires Servier in the largest case to date concerning patent settlement agreements in the pharmaceutical sector, involving the application of both Articles 101 and 102.
Representation of clients before the European Commission in Phase 1 and Phase 2 merger control reviews, including the acquisition by Metso Corporation of pulp machinery equipment competitor Aker Kvaerner (COMP/M.4187), and the acquisition of Italian company Eco by the Finnish group Luvata (COMP/M. 4750).
Assisted the COMESA Competition Commission on the preparation of antitrust guidelines implementing its competition regulations.
The review of the hearing officers' terms of reference and European Commission Best Practices in Antitrust Proceedings in 2011.*
Various cartel investigations, including the freight forwarding case (case 39462).*
Merger control phase 2 proceedings, notably: Olympic/Aegean I (M.5830) and Deutsche Börse/NYSE Euronext (M.6166) (both prohibition decisions); UPM-Kymmene/Myllykoski Paper (M.6342); Johnson & Johnson/Synthes (M.6266); SC Johnson /Sara Lee (M.5969); Western Digital/Viviti (M.6203); and Caterpillar/MWM (M.6106).*
* Experience at the European Commission (Hearing Officers' team)
"KPN BV v European Commission: EU Merger Clearance Annulled for Insufficient Reasoning", Journal of European Competition Law & Practice, Volume 9, Issue 5, pp. 317-319, May 2018
"Droits procéduraux des entreprises dans les procédures de cartel de l’Union européenne", Journal de droit européen 2013, v. 21, n. 204, p. 381, December 2013
"Relying on legal advice does not prevent a fine says ECJ", Lexis Nexis, June 2013 (with J. Killick)
Who's Who Legal: Competition – Future Leaders, 2017, 2018, 2019